GlassScriptPhysician profile
Lauren E Boles
NPI 1235633876
$7,450.08
in general payments reported to CMS, 2019-2025
9 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $1,181 · 2023: $1,831 · 2024: $2,451 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,419 · Travel and Lodging: $300 · Consulting Fee: $200 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,418.81 |
| Travel and Lodging | $300.14 |
| Consulting Fee | $200.00 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $5,356.19 | 2021-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,042.45 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $434.65 | 2024-2025 | Lumryz |
| Harmony Biosciences LLC | $386.83 | 2021-2024 | Wakix |
| Idorsia Pharmaceuticals US INC | $121.85 | 2022 | |
| Axsome Therapeutics, INC. | $42.71 | 2023 | Sunosi |
| Fisher & Paykel Healthcare INC | $33.72 | 2022 | |
| Resmed Corp | $18.30 | 2024 | |
| Ucb, INC. | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Boles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.